Re-emergence of striatal cholinergic interneurons in movement disorders
The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Primate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
The Basal Ganglia and Adaptive Motor Control
Graybiel, A. M., Aosaki, T., Flaherty, A. W., & Kimura, M. (1994) · Science · doi:10.1126/science.8091209 · Cited by 1,324
Striatal interneurones: chemical, physiological and morphological characterization
Kawaguchi, Y., Wilson, C. J., Augood, S. J., & Emson, P. C. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)98374-8 · Cited by 1,198
Biochemical pathophysiology of Parkinson's disease.
Hornykiewicz, O., & Kish, S. J. (1987) · PubMed · Cited by 849
Pathophysiology of the basal ganglia in Parkinson's disease
Obeso, J. A., Rodriguez-Oroz, M. C., Rodriguez, M., Lanciego, J. L., Artieda, J., Gonzalo, N., & Olanow, C. W. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00028-8 · Cited by 844
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum
Gerdeman, G. L., Ronesi, J., & Lovinger, D. M. (2002) · Nature Neuroscience · doi:10.1038/nn832 · Cited by 767
Long-term synaptic depression in the striatum: physiological and pharmacological characterization
Calabresi, P., Maj, R., Pisani, A., Mercuri, N., & Bernardi, G. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-11-04224.1992 · Cited by 673
Self-citation
Cited by
Modulation of Striatal Projection Systems by Dopamine
Gerfen, C. R., & Surmeier, D. J. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113641 · Cited by 1,718
Self-citationCalabresi, P., Mechelli, A., Natale, G., Volpicelli-Daley, L., Di Lazzaro, G., & Ghiglieri, V. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05672-9 · Cited by 817
Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline
Ballinger, E. C., Ananth, M., Talmage, D. A., & Role, L. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.006 · Cited by 730
The cholinergic system and Parkinson disease
Bohnen, N. I., & Albin, R. L. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.048 · Cited by 566
Current Concepts and Treatments of Schizophrenia
Stępnicki, P., Kondej, M., & Kaczor, A. A. (2018) · Molecules · doi:10.3390/molecules23082087 · Cited by 556
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
The pathophysiological basis of dystonias
Breakefield, X. O., Blood, A. J., Li, Y., Hallett, M., Hanson, P. I., & Standaert, D. G. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2337 · Cited by 448
Deep Brain Stimulation for Neurologic and Neuropsychiatric Disorders
Wichmann, T., & DeLong, M. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.022 · Cited by 331
Raymond, L. A., André, V. M., Cepeda, C., Gladding, C. M., Milnerwood, A. J., & Levine, M. S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.052 · Cited by 325
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease
Huot, P., Johnston, T. H., Koprich, J. B., Fox, S. H., & Brotchie, J. M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005678 · Cited by 324
Striatal origin of the pathologic beta oscillations in Parkinson's disease
McCarthy, M. M., Moore-Kochlacs, C., Gu, X., Boyden, E. S., Han, X., & Kopell, N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107748108 · Cited by 314
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders
Conn, P. J., Jones, C. K., & Lindsley, C. W. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.12.002 · Cited by 286
Dopamine release in the basal ganglia
Rice, M. E., Patel, J. C., & Cragg, S. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.066 · Cited by 282
Dystonia as a network disorder: What is the role of the cerebellum?
Prudente, C. N., Hess, E. J., & Jinnah, H. A. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.062 · Cited by 262
Acetylcholine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
Lester, D. B., Rogers, T. D., & Blaha, C. D. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00142.x · Cited by 259
Cholinergic interneurons mediate fast VGluT3-dependent glutamatergic transmission in the striatum
Higley, M. J., Gittis, A. H., Oldenburg, I. A., Balthasar, N., Seal, R. P., Edwards, R. H., Lowell, B. B., Kreitzer, A. C., & Sabatini, B. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019155 · Cited by 175
“Recordings were made at room temperature to reduce spontaneous firing of CINs [17].”
BackgroundDi Filippo, M., Picconi, B., Tantucci, M., Ghiglieri, V., Bagetta, V., Sgobio, C., Tozzi, A., Parnetti, L., & Calabresi, P. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.025 · Cited by 158
“This autonomous activity of cholinergic interneurons has led to them being referred to as ‘tonically active neurons’ (TANs) in behaving animals [57].”
Muscarinic modulation of striatal function and circuitry
Goldberg, J. A., Ding, J. B., & Surmeier, D. J. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-23274-9_10 · Cited by 150
Self-citationDeconstructing behavioral neuropharmacology with cellular specificity
Shields, B. C., Kahuno, E., Kim, C., Apostolides, P. F., Brown, J., Lindo, S., Mensh, B. D., Dudman, J. T., Lavis, L. D., & Tadross, M. R. (2017) · Science · doi:10.1126/science.aaj2161 · Cited by 135
Multiphasic modulation of cholinergic interneurons by nigrostriatal afferents
Straub, C., Tritsch, N. X., Hagan, N. A., Gu, C., & Sabatini, B. L. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0589-14.2014 · Cited by 130
“Importantly, their dysfunction is implicated in Parkinson’s disease and other movement disorders (Pisani et al., 2007).”
Cholinergic modulation of multivesicular release regulates striatal synaptic potency and integration
Higley, M. J., Soler-Llavina, G. J., & Sabatini, B. L. (2009) · Nature Neuroscience · doi:10.1038/nn.2368 · Cited by 110
Stillman, A. A., Krsnik, Ž., Sun, J., Rašin, M., State, M. W., šestan, N., & Louvi, A. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.21919 · Cited by 95
“Recent experimental and clinical studies have implicated striatal cholinergic interneurons in the induction of synaptic plasticity and motor learning as well as in motor dysfunction, causing a renewed interest in their role in movement disorders (Pisani et al., 2007).”
BackgroundFunctional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease
Galvan, L., André, V. M., Wang, E. A., Cepeda, C., & Levine, M. S. (2012) · Journal of Huntington's Disease · doi:10.3233/jhd-2012-120009 · Cited by 56
Crittenden, J. R., Zhai, S., Sauvage, M., Kitsukawa, T., Burguière, E., Thomsen, M., Zhang, H., Costa, C., Martella, G., Ghiglieri, V., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105473 · Cited by 19
Self-citation
Metadata
- Authors
- Pisani, A., Bernardi, G., Ding, J., & Surmeier, D. J.
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 30
- Issue
- 10
- Pages
- 545-553
- ISSN
- 0166-2236 (ISSN-L)
- OpenAlex
- W2023796931
- Cited by
- 466
- References
- 78
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.